Myocarditis following COVID-19 mRNA vaccination

BACKGROUND: Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. METHODS: Patients were identified upon presentation to the emergency department with symptoms of chest pain/discomfort. In all stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine
Hauptverfasser: Abu Mouch, Saif, Roguin, Ariel, Hellou, Elias, Ishai, Amorina, Shoshan, Uri, Mahamid, Lamis, Zoabi, Marwan, Aisman, Marina, Goldschmid, Nimrod, Berar Yanay, Noa
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier Ltd. 2021
Schlagworte:
Short Communication
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8162819/
https://ncbi.nlm.nih.gov/pubmed/34092429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2021.05.087
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge